ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported a loss of $5.4 million in its fourth quarter.
On a per-share basis, the Alachua, Florida-based company said it …
Please log in to continue |
ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported a loss of $5.4 million in its fourth quarter.
On a per-share basis, the Alachua, Florida-based company said it had a loss of 13 cents. Losses, adjusted for stock option expense and non-recurring costs, were 3 cents per share.
The regenerative medicine company posted revenue of $36.2 million in the period.
AxoGen expects full-year revenue in the range of $154 million to $159 million.
AxoGen shares have fallen 25% since the beginning of the year. The stock has dropped 9.5% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN
